This study compares the therapeutic effect of increasing fluid viscosity with two types of TP (MS, XG) versus that of six compounds of three families of TRP agonists (TRPV1, TRPA1 and TRPM8) in order to identify the optimal components to develop an active pharmacological treatment for patients with OD. Here, TRPV1 is linked to osteochondritis dissecans.